Literature DB >> 1967043

Levels of zinc and thymulin in plasma from patients with Crohn's disease.

E Mocchegiani1, C Brignola, P Iannone, M Campieri, M Pasquali, G A Lanfranchi, L Barbara, N Fabris, F Licastro.   

Abstract

Levels of zinc in plasma from patients with Crohn's disease were significantly lower than those of sex and age matched controls. We also measured the level of plasmic thymulin, a hormone released by the thymus gland, which in its active form binds one zinc molecule. The zinc unbound form of thymulin is biologically inactive and its level in the blood is a very sensitive marker of even marginal zinc deficiency. Levels of active thymulin were significantly reduced in plasma from patients with Crohn's disease, whereas plasma concentrations of the inactive form was higher than in controls. The in vitro addition of zinc ions restored thymulin activity in plasma from patients with Crohn's disease, and induced the disappearance of the inactive form. These findings suggest the existence of a zinc dependent alteration regarding the biological function of thymic hormones in patients with Crohn's disease. Such a defect might explain some of the immunological abnormalities observed in these pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967043

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  2 in total

1.  Comparison of Thymulin Activity with Other Measures of Marginal Zinc Deficiency.

Authors:  Robert A DiSilvestro; Mireille Dardenne; Elizabeth Joseph
Journal:  Biol Trace Elem Res       Date:  2020-05-03       Impact factor: 3.738

2.  Impaired peripheral zinc metabolism in patients with senile dementia of probable Alzheimer's type as shown by low plasma concentrations of thymulin.

Authors:  F Licastro; L J Davis; E Mocchegiani; N Fabris
Journal:  Biol Trace Elem Res       Date:  1996-01       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.